ARTICLE | Company News
FDA approves Abbott's Simcor
February 16, 2008 1:28 AM UTC
FDA approved an NDA from Abbott (NYSE:ABT) for Simcor, a fixed-dose combination of extended-release niacin and immediate-release simvastatin, to manage cholesterol levels in patients with complex lipi...